Top Markets
#1 Akedo Akedo +61.14%
#2 Glidr Glidr +51.75%
#3 DOVU DOVU +49.20%
#4 Cross Cross +47.31%
#5 Black Phoenix Black Phoenix +34.31%
#6 Velvet Velvet +29.27%
#7 OVERTAKE OVERTAKE +25.19%
#8 Not in Employment, Education, or Training Not in Employment, Education, or Training +16.05%
#9 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +14.98%
#10 Movement Movement +14.11%
Coin of the day
Akedo Akedo
Settings
Language
ENGLISH
Currency
USD
Theme
Solarvest BioEnergy Inc. Solarvest BioEnergy Inc.

Solarvest BioEnergy Inc.

SVS
Rank in Stocks #38860
Solarvest BioEnergy Inc. specializes in harnessing algal-based production... Solarvest BioEnergy Inc. specializes in harnessing algal-based production systems to develop natural, environmentally friendly commercial products for both Canadian and international markets. The company's offerings span human nutrition, including omega-3; a clean energy solution for continuous hydrogen production; and pharmaceutical components for human health. These pharmaceutical applications specifically include cannabinoids derived from algae and bone morphogenetic protein for treating bone fractures. Solarvest BioEnergy Inc. also has a collaborative research and development agreement with FSD Pharma Inc. to create pharmaceutical-grade cannabinoids using algae. Established in 2005, the company is headquartered in Vancouver, Canada.
Share Price
$0.01823546
Last synced: 2023-10-03
Market Cap
$767.12K
Change (1 day)
-0.22%
Change (1 year)
0.00%
Country
CA
Trade Solarvest BioEnergy Inc. (SVS)

Category

Healthcare
Number of shares outstanding for Solarvest BioEnergy Inc. (SVS)
Number of shares outstanding as of August 2026: 0
According to Solarvest BioEnergy Inc. latest financial reports and stock price the company's current number of shares outstanding is 0. At the end of August 2026 the company had 0 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Solarvest BioEnergy Inc. (SVS) from 2026 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
Not enough data for the provided dates.
Shares Outstanding for similar companies or competitors
Company Shares Outstanding Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 0.00 -
BE